Clinical Trials
29 trialsNivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Observing People With Desmoid-Type Fibromatosis
Memorial Sloan Kettering Cancer Center
Embodesmo
Istituto Ortopedico Rizzoli
ECT-DESMO
Istituto Ortopedico Rizzoli
Cryomics
Istituto Ortopedico Rizzoli
Individual Patient Compassionate Use of Nirogacestat
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
A Study in Adults With Desmoid Tumors
Elpiscience Biopharma, Ltd.
PRISM
Dana-Farber Cancer Institute
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Children's Oncology Group
ALTITUDES
Centre Oscar Lambret
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PALANGI3
Centre Oscar Lambret
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
Eisai Inc.
RINGSIDE
Immunome, Inc.
SarcAblate
Oxford University Hospitals NHS Trust
CRYODESMO01
University Hospital, Strasbourg, France
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
CRYODESMO-02
University Hospital, Strasbourg, France
TAE-DESMO
Istituto Ortopedico Rizzoli
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
PROSa Desmoid
Technische Universität Dresden
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli